125 related articles for article (PubMed ID: 21677469)
1. Changing pathology with changing drugs.
Borisch B; Hoessli D
Pathobiology; 2011; 78(2):59-60. PubMed ID: 21677469
[No Abstract] [Full Text] [Related]
2. DNA repair: a reinvigorated therapeutic target.
Bates SE
Clin Cancer Res; 2010 Sep; 16(18):4510. PubMed ID: 20823139
[No Abstract] [Full Text] [Related]
3. Changing pathology with changing drugs: skin cancer.
Karpova MB; Barysch MJ; Zipser MC; Schönewolf N; French LE; Dummer R
Pathobiology; 2011; 78(2):61-75. PubMed ID: 21677470
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapeutics and implications for pathologists.
Geyer SJ; Johnson PC
Am J Clin Pathol; 2002 Jul; 118(1):144; author reply 144. PubMed ID: 12109849
[No Abstract] [Full Text] [Related]
5. The advent of targeted therapeutics and implications for pathologists.
Hess JL
Am J Clin Pathol; 2002 Mar; 117(3):355-7. PubMed ID: 11888074
[No Abstract] [Full Text] [Related]
6. The evolution of bone-targeted therapies: introduction.
Gnant M
Semin Oncol; 2010 Oct; 37 Suppl 2():S1. PubMed ID: 21111243
[No Abstract] [Full Text] [Related]
7. Genetic tumor profiling and genetically targeted cancer therapy.
Goetsch CM
Semin Oncol Nurs; 2011 Feb; 27(1):34-44. PubMed ID: 21255711
[TBL] [Abstract][Full Text] [Related]
8. The next generation of antibody-drug conjugates comes of age.
Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
[TBL] [Abstract][Full Text] [Related]
9. Combining molecular targeted therapeutics (MTT) and radiotherapy: MTT and MTD.
Brunner T; McKenna G
Eur J Cancer; 2011 Sep; 47 Suppl 3():S373-4. PubMed ID: 21944020
[No Abstract] [Full Text] [Related]
10. [Breakthroughs in cancer treatment].
Rørth M
Ugeskr Laeger; 2011 Jun; 173(24):1721-4. PubMed ID: 21696676
[TBL] [Abstract][Full Text] [Related]
11. Advances in targeted therapies XII. Preface.
Breedveld FC; Kalden JR; Smolen JS
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
[No Abstract] [Full Text] [Related]
12. [Feature articles: current status and future direction of the treatment of hematological disorders with molecular-targeting agents (1)].
Kizaki M
Rinsho Ketsueki; 2011 Jul; 52(7):433-7. PubMed ID: 21821973
[No Abstract] [Full Text] [Related]
13. Combining targeted drugs to stop resistant tumors.
Kaiser J
Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
[No Abstract] [Full Text] [Related]
14. Asthma: developments in targeted therapy.
Matucci A; Vultaggio A; Ridolo E; Maggi E; Canonica GW; Rossi O
Expert Rev Clin Immunol; 2012 Jan; 8(1):13-5. PubMed ID: 22149334
[No Abstract] [Full Text] [Related]
15. The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients.
Barry JJ; Jian BJ; Sughrue ME; Kane AJ; Mills SA; Tihan T; Parsa AT
Neurosurgery; 2011 Jan; 68(1):231-40; discussion 240-1. PubMed ID: 21099719
[TBL] [Abstract][Full Text] [Related]
16. Myeloma researchers gain genome, new targets, and new concerns.
Brower V
J Natl Cancer Inst; 2011 Jul; 103(14):1082-5. PubMed ID: 21737696
[No Abstract] [Full Text] [Related]
17. [Impact of the pathology in modern medicine].
Brousset P; Delsol G
Med Sci (Paris); 2011; 27(6-7):651-5. PubMed ID: 21718650
[TBL] [Abstract][Full Text] [Related]
18. Getting personal.
Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
[No Abstract] [Full Text] [Related]
19. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
Quant EC; Wen PY
Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
Muñoz M; Coveñas R
Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
